FDA provides $14M for orphan drug work; Flagship launches 'pharmaconutrient' developer; Investigators say new method could cure baldness;

@FierceBiotech: ICYMI yesterday: 20 BigPharma and biotech mobile apps - 2013. Report | Follow @FierceBiotech

@JohnCFierce: Good thing we have archives--Pain surges after Pfizer commits to 3rd try for long-delayed pain drug Remoxy. Story | Follow @JohnCFierce

@DamianFierce: It's another Class I recall for CareFusion, and these things are starting to catch up with revenue, it seems. News | Follow @DamianFierce

> The FDA has handed out $14 million in new grants to support the development of new orphan drugs and devices. Release

> Flagship VentureLabs is launching a new company, Pronutria, with a $10.8 million Series A. The company says it plans to build "pharmaconutrients" into a major new class of products. Release

> San Diego-based Arcturus Therapeutics raised a $5 million Series A round to fund its work on RNAi technology. Release

Medical Device News

@FierceMedDev: New special report: Top Med Tech Investments of Q3. Report | Follow @FierceMedDev

@MarkHFierce: For Boston Scientific, the first vaginal mesh implant lawsuits are slated to begin in March. Will the company settle? Item | Follow @MarkHFierce

@MichaelGFierce: Implantable, light-sensitive hydrogel could help treat diabetes. More from FierceDrugDelivery | Follow @MichaelGFierce

> Qiagen inks lung cancer diagnostics deal with Clovis Oncology. Story

> CareFusion's latest malfunction draws FDA's most serious label. Article

> European Parliament advances regs that would strengthen scrutiny of high-risk devices. News

> With FDA nod, Cardiovascular Systems targets $1.5B market. More

Pharma News

@FiercePharma: Two most popular profiles from our Top 10 generics makers report: Teva and Sandoz | Follow @FiercePharma

@CarlyHFierce: Check out the top 10 DTC pharma advertisers from 2013 H1 in the new report. | Follow @CarlyHFierce

> Report: Feds get big 'bang for the buck' in fighting pharma fraud. Story

> Still free from Diovan rivals, Novartis hikes forecast once again. Report

Biotech Research News

@EmilyMFierce:  | Follow @EmilyMFierce

> Harvard, AstraZeneca partner to replace animal testing with 'organs-on-chips.' More

> Takeda, Hopkins developing new pancreatic cancer drugs. Story

> Novartis CDK 4/6 cancer drug effective in preclincal tests, advances to PhI. Item

> New approach could lead to universal flu vaccine. Article

> Mini pancreas grown in lab using mouse cells. Story

Pharma Manufacturing News

@EricPFierce: Is there a connection between pharma DTC spending and job cuts? In some cases, yes. FiercePharma special report | Follow @EricPFierce

> U.K. takes enforcement action against third Wockhardt plant. More

> Authorities seize large load of fake Xanax headed for Egypt. Story

> Teva API plant workers strike over wage gaps. Article

> German contract manufacturers invest €70 million on expansions. Item

> Teva opens $100M Croatia plant as it cuts elsewhere. Report

> Biocad taking biosimilar production to Brazil. More

And Finally… Investigators say they successfully cloned cells found in the scalp and transplanted them onto the backs of mice, pointing to a new way to possibly cure baldness one day. Story

Suggested Articles

When thinking about clinical research patient recruitment, a crucial step is building effective patient recruitment advertising campaigns.

Novavax delayed the start of a large phase 3 trial for its COVID-19 vaccine in the U.S. and Mexico, thanks to delays in scaling up manufacturing.

The decision to dump IL33r antagonist GSK3772847 follows lackluster clinical data on rival candidates against the same target.